TELA BIO INC (TELA)

US8723811084 - Common Stock

6.18  +0.2 (+3.34%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
29.46M
61.78%		41.42M
40.60%		58.453M
41.12%		76.374M
30.66%
EBITDA
YoY % growth
-28.92M
-16.80%		-37.83M
-30.81%		-43.267M
-14.37%		-38.42M
11.20%
EBIT
YoY % growth
-29.45M
-16.50%		-39.01M
-32.46%		-44.075M
-12.98%		-35.977M
18.37%
Operating Margin
-99.97%-94.18%-75.40%-47.11%
EPS
YoY % growth
-2.29
-2.69%		-2.70
-17.90%		-2.07
23.33%		-1.78
14.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.51
18.79%
Revenue
Q2Q % growth		16.645M
39.76%
EBITDA
Q2Q % growth		-11.06MN/AN/AN/AN/A
EBIT
Q2Q % growth		-12.395M
-10.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.23
63.49%		-0.510.2855.05%
Q4 2023
Q2Q % growth		 -0.53
-1.92%		-0.44-0.09-19.51%
Q3 2023
Q2Q % growth		 -0.45
29.69%		-0.500.0510.29%
Q2 2023
Q2Q % growth		 -0.46
41.77%		-0.540.0815.39%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 16.998M
46.28%		16.72M278K1.66%
Q3 2023
Q2Q % growth		 15.05M
34.86%		16.52M-1.47M-8.90%
Q2 2023
Q2Q % growth		 14.49M
39.19%		14.69M-200K-1.36%
Q1 2023
Q2Q % growth		 11.91M
44.71%		12.259M-349K-2.85%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.4% -17.82% 0% -11.09%
Revenue-0.11% 0.74% 0% -0.43%